NCT01594554View on ClinicalTrials.gov

A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

September 30, 2016

Conditions
Hepatitis C
Trial Locations (1)

100044

RECRUITING

Wei Lai, Beijing

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Peking University People's Hospital

OTHER